Brief: Bluebird Bio Inc - As Result of Restructuring Will Incur Aggregate Charges Of About $3.7 Million In Cash Expenditures
Sept 24 (Reuters) - bluebird bio Inc BLUE.O :
* BLUEBIRD BIO INC - AS RESULT OF RESTRUCTURING, ESTIMATES
THAT IT
WILL INCUR AGGREGATE CHARGES OF ABOUT $3.7 MILLION IN CASH
EXPENDITURES
* BLUEBIRD BIO: RESTRUCTURING CHARGES TO BE PAID OUT OVER
MULTIPLE
WEEKS THROUGH FISCAL YEAR ENDING DEC 31 END
Source text for Eikon: ID:n0001293971-24-000046
Further company coverage: BLUE.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment